{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-040790","form_type":"8-K","ticker":"NUS","cik":"0001021561","company_name":"NU SKIN ENTERPRISES, INC.","filed_at":"2025-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.561723+00:00","generated_at":"2026-05-16T23:19:20.846894+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Nu Skin Q3 revenue $364.2M (-15.3% YoY); EPS $0.34 in line with guidance","bullets":["Revenue $364.2M, down 15.3% YoY (down 11.5% ex-Mavely); EPS $0.34 vs $0.17 prior year.","Customers 746,256 (-10%), Paid Affiliates 130,096 (-13%), Sales Leaders 31,150 (-19% YoY).","Gross margin improved to 70.5% from 70.1%; Nu Skin business gross margin 77.7% vs 76.5%.","Q4 2025 revenue outlook $365-400M, EPS $0.25-0.35; FY 2025 revenue $1.48-1.51B, EPS $3.15-3.25.","Preparing for limited Prysm iO launch and pre-market opening in India; paid $3.0M dividends, $5.0M buybacks."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-040790","json":"https://secwatch.observer/filing/0001140361-25-040790.json","markdown":"https://secwatch.observer/filing/0001140361-25-040790.md","text":"https://secwatch.observer/filing/0001140361-25-040790.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1021561/000114036125040790/0001140361-25-040790-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1021561/000114036125040790/ef20058443_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T23:19:20.846894+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}